Sint Franciscus Vlietland Groep Stichting

At Sint Franciscus Vlietland Groep Stichting, clinical trials in cardiology focus on major cardiovascular diseases such as atrial fibrillation, atherosclerotic cardiovascular disease, stroke, and heart failure. These studies aim to evaluate new ways to prevent serious events, improve long-term outcomes, and refine treatment choices for people at elevated risk.

• Stroke prevention and embolic risk reduction in atrial fibrillation
• Cardiovascular event prevention in patients with high-risk atherosclerotic disease
• Heart failure and kidney-related outcome studies
• Lipid-lowering approaches for better control of cardiovascular risk

Overall, this research area is centered on testing therapies that may lower the chance of heart attack, stroke, and other major complications while supporting safer, more effective prevention strategies.

The site is active in cancer research across prostate cancer, breast cancer, renal cell carcinoma, lung cancer, colorectal cancer, and several lymphomas and leukemias. Many studies are designed to compare treatment effectiveness, improve survival, and explore more personalized approaches for people with advanced or recurrent disease.

• Prostate cancer and metastatic renal cell carcinoma treatment strategies
• Breast cancer and lung cancer therapy evaluation
• Lymphoma and leukemia studies focused on response and disease control
• Targeted oncology research for tumors with specific biological markers

These trials often aim to improve survival, delay progression, or reduce treatment burden by identifying better combinations or more tailored options for patients with difficult-to-treat cancers.

Clinical studies in digestive system diseases and immune-mediated inflammation include Crohn’s disease, ulcerative colitis, non-alcoholic steatohepatitis, pancreatitis, and colorectal cancer. The research is aimed at improving symptom control, preventing recurrence, and finding better treatments for chronic and acute conditions affecting the gut and liver.

• Crohn’s disease and ulcerative colitis treatment improvement
• NASH and liver health research
• Pancreatitis studies seeking to reduce complications
• Colorectal cancer recurrence prevention after surgery

This field combines therapy testing with efforts to better understand how inflammation and organ injury can be managed more effectively in everyday care.

The research portfolio also includes respiratory tract diseases such as asthma, COPD, lower respiratory infections, and bronchiolitis. At this hospital, trials in this area are focused on improving breathing support, reducing exacerbations, and evaluating treatments that may help patients recover more safely from acute illness.

• Severe asthma and eosinophilic airway disease
• COPD and chronic respiratory symptom control
• Respiratory infections in hospitalized patients and infants
• Critical care approaches for patients with breathing failure

Several studies in this area aim to improve treatment effectiveness while also helping clinicians choose safer, more practical ways to support patients with serious breathing disorders.

Trials in kidney disease, metabolic disorders, and endocrine conditions cover chronic kidney disease, IgA nephropathy, diabetes, obesity, hypothyroidism, and related complications. The main purpose is to test therapies that may preserve organ function, improve metabolic control, and reduce long-term risk.

• Chronic kidney disease and IgA nephropathy management
• Type 2 diabetes and obesity treatment studies
• Hormonal and thyroid disorders including Graves’ disease and hypothyroidism
• Kidney and cardiovascular protection in high-risk patients

Research in this cluster often looks beyond symptom control, aiming to slow disease progression and support better quality of life over time.

Another important area covers immune system diseases and rheumatologic conditions such as rheumatoid arthritis, polymyalgia rheumatica, ANCA vasculitis, and Crohn’s disease. These studies are generally designed to improve immune control, reduce inflammation, and test whether newer treatments can maintain disease control with fewer side effects.

• Rheumatoid arthritis and chronic joint inflammation
• Polymyalgia rheumatica symptom control and steroid-sparing care
• Vasculitis and other inflammatory immune disorders
• Biomarker-guided treatment optimization in immune disease

These trials reflect a strong interest in balancing effectiveness with long-term tolerability for patients living with persistent inflammatory disease.

The site also supports studies in nervous system diseases and otorhinolaryngologic disorders, including ischemic stroke, Menière’s disease, and viral wheeze. In addition, there are projects involving health care economics, public health, and diagnostic and therapeutic techniques, showing a broad interest in practical improvements to patient care.

• Stroke recovery and prevention research
• Menière’s disease and vertigo symptom management
• Pediatric respiratory distress and supportive care optimization
• Health care delivery and cost-effectiveness studies

These investigations aim to improve both clinical outcomes and the way care is organized, making treatment more effective and more sustainable for patients and health systems.